SCHEMBL23818950

SCHEMBL23818950

CCOC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OCC)OC[C@@]1(C)O[C@@H](c2ccc3c(NC(=O)C(C)C)ncnn23)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26344794 0.98 — —
SCHEMBL23818693 0.94 — —
SCHEMBL26331355 0.90 TMPRSS2 (0.31) —
SCHEMBL23818585 0.88 TMPRSS2 (0.32) —
SCHEMBL26229754 0.86 — —
SCHEMBL23818577 0.85 TMPRSS2 (0.33) —
SCHEMBL26334199 0.84 BTN3A1 (0.39) —
SCHEMBL26333935 0.84 POLRMT (0.38) —
SCHEMBL23818965 0.83 — —
SCHEMBL23819056 0.83 POLRMT (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback